"10.1371_journal.pone.0093863","plos one","2014-04-07T00:00:00Z","Stefanie Voigtsberger; Martin Urner; Melanie Hasler; Birgit Roth Z'Graggen; Christa Booy; Donat R Spahn; Beatrice Beck-Schimmer","Institute of Anesthesiology, University Hospital Zurich, Zurich, Switzerland,; Institute of Physiology and Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland","Conceived and designed the experiments: SV DRS BBS. Performed the experiments: SV MH BRZ CB. Analyzed the data: MU SV MH BRZ CB BBS DRS. Contributed reagents/materials/analysis tools: BBS. Wrote the paper: SV MU DRS BBS.","The authors have read the journals policy. The authors have the following conflicts: Prof. Donat R Spahns academic department is receiving grant support from the CSL Behring, Berne, Switzerland (no grant numbers are attributed), Vifor SA, Villars-sur-Glâne, Switzerland (no grant numbers are attributed). Prof. Donat R Spahn was the chairman of the ABC Faculty and is a member of the ABC-Trauma Faculty, which both are managed by Physicians World Europe GmbH, Mannheim, Germany and sponsored by unrestricted educational grants from Novo Nordisk Health Care AG, Zurich, Switzerland and CSL Behring GmbH, Marburg, Germany. In the past 5 years, Prof. Donat R Spahn has received honoraria or travel support for consulting or lecturing from the following companies: Abbott AG, Baar, Switzerland, AMGEN GmbH, Munich, Germany, AstraZeneca AG, Zug, Switzerland, Bayer (Schweiz) AG, Zürich, Switzerland, Baxter AG, Volketswil, Switzerland, Baxter S.p.A., Roma, Italy, B. Braun Melsungen AG, Melsungen, Germany, Boehringer Ingelheim (Schweiz) GmbH, Basel, Switzerland, Bristol-Myers-Squibb, Rueil-Malmaison Cedex, France and Baar, Switzerland, CSL Behring GmbH, Hattersheim am Main, Germany and Berne, Switzerland, Curacyte AG, Munich, Germany, Ethicon Biosurgery, Sommerville, New Jersey, USA, Fresenius SE, Bad Homburg v.d.H., Germany, Galenica AG, Bern, Switzerland (including Vifor SA, Villars-sur-Glâne, Switzerland), GlaxoSmithKline GmbH & Co. KG, Hamburg, Germany, Janssen-Cilag AG, Baar, Switzerland, Janssen-Cilag EMEA, Beerse, Belgium, Merck Sharp & Dohme-Chibret AG, Opfikon-Glattbrugg, Switzerland, Novo Nordisk A/S, Bagsvärd, Denmark, Octapharma AG, Lachen, Switzerland, Organon AG, Pfäffikon/SZ, Switzerland, Oxygen Biotherapeutics, Costa Mesa, CA, Pentapharm GmbH (now tem Innovations GmbH), Munich, Germany, ratiopharm Arzneimittel Vertriebs-GmbH, Vienna, Austria, Roche Pharma (Schweiz) AG, Reinach, Switzerland, Schering-Plough International, Inc., Kenilworth, New Jersey, USA, Vifor Pharma Deutschland GmbH, Munich, Germany, Vifor Pharma Österreich GmbH, Vienna, Austria, Vifor (International) AG, St. Gallen, Switzerland. Prof. Beatrice Beck-Schimmer was supported by the Swiss National Science Foundation Grant (Nr. 3200B0-122305) and B. Braun, Melsungen, Germany. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","04","Stefanie Voigtsberger","SV",7,TRUE,3,4,7,4,TRUE,TRUE,FALSE,0,NA,FALSE
